Advocates on Steps of Congress 2013
Please leave this field empty
Scleroderma Foundation
Having trouble with this message? View it online.
scleroderma horizontal logo.jpg Facebook Twitter YouTube Inspire

cme save the date.jpg

PIM 4C logo - 2013.jpg       Scleroderma Foundation

Jointly sponsored/co-provided by Postgraduate Institute for Medicine and The Scleroderma Foundation.

Virginia Steen, M.D., Georgetown University Medical Center, Washington, D.C., Moderator
Philip Clements, M.D., UCLA Medical Center, Los Angeles, CA
Aryeh Fischer, M.D., National Jewish Health, Denver, CO

Program Agenda

8:00 a.m. - 8:45 a.m. Registration & Breakfast
8:45 a.m. - 9:30 a.m. Pulmonary Fibrosis in Scleroderma- Philip Clements, M.D.
9:30 a.m. - 10:15 a.m. PH in Scleroderma - Aryeh Fischer, M.D.
10:15 a.m. - 10:30 a.m. Break
10:30 a.m. - 11:00 a.m. Panel Discussion: Dr. Clements, Dr. Fischer, and Dr. Steen, Moderator
11:00 a.m. - 11:15 a.m. Bring Your Case
Attendees will have an opportunity to discuss their cases with the panel

PRE-REGISTRATION IS REQUIRED. Please register for this event by Friday, July 26 by clicking on the link below. Or contact Kerri A. Connolly at

The general objective will be to raise awareness about early diagnosis of SSc-pulmonary hypertension and SSc- interstitial lung disease to discuss ways to effectively treat and manage the conditions. This will involve recent/appropriate/updated knowledge dissemination to clinicians and patients.

This activity has been designed to meet the educational needs of physicians, registered nurses, and other health care professionals involved in the management of patients with scleroderma.

After completing this activity, the participant should be better able to:

  • Develop material to increase awareness about the need for early diagnosis and treatment of pulmonary hypertension and interstitial fibrosis in systemic sclerosis.
  • Implement recent updates on the diagnostic methods and outcome measures used in scleroderma patients with pulmonary hypertension or interstitial fibrosis.
  • Discuss special circumstances where evaluation of prognosis and appropriate modification of treatment requires additional debate/discussion.

Fee Information
There is no fee for this educational activity. Hotel valet parking will be validated.

Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and The Scleroderma Foundation.  The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
Credit Designation
This educational activity for 2.2 contact hours is provided by Postgraduate Institute for Medicine.

Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Kerri A. Connolly prior to the live event at 800-722-4673.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within three weeks.

actelion new.jpg

This activity is supported by an educational grant from Actelion Pharmaceuticals US

Donate Now
  Unsubscribe | Visit our website